FrancophonIA/ELRC3.0 huggingface dataset:
English: The prescribed amount of solution should be withdrawn from the bottle using the oral dosing syringe supplied.
Estonian: Vajalik kogus lahust võetakse pudelist kaasasoleva annustamissüstlaga.
English: Attaching the syringe to the bottle • Push the nozzle of the syringe into the hole in the white stopper.
Estonian: Süstla viimine pudelisse • Asetage süstla ots valge aluskorgi avasse.
English: Rivastigmine oral solution may be swallowed directly from the syringe.
Estonian: Rivastigmiini suukaudne lahus tuleb otse süstlast alla neelata.
English: Caution when Rivastigmine HEXAL is taken together with beta-blockers (medicines such as atenolol used to treat hypertension, angina and other heart conditions).
Estonian: Olge ettevaatlik, kui Rivastigmine HEXAL'it võetakse koos beetablokaatoritega (ravimid, nt atenolool, millega ravitakse hüpertensiooni, stenokardiat ja muid südamehaigusi).
English: Fatigue and asthenia Malaise
Estonian: Väsimus ja asteenia Haiglane olek Kukkumine
English: - Capsule fill: - Microcrystaline cellulose - Magnesium stearate - Hypromellose - Silica, colloidal anhydrous
Estonian: Kapsli sisu: - mikrokristalne tselluloos - magneesiumstearaat - hüpromelloos - kolloidne veevaba ränidioksiid
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON FOR ALU/PVC BLISTER
Estonian: VÄLISPAKENDIL PEAVAD OLEMA JÄRGMISED ANDMED ALU/PVC BLISTERPAKENDI KARP
English: Patients with severe hepatic impairment have not been studied, however, rivastigmine oral solution may be used in this patient population provided close monitoring is exercised (see sections 4.4 and
Estonian: Tõsiste maksakahjustustega patsiente ei ole uuritud, kuid rivastigmiini suukaudset lahust võib sellel patsientide rühmal kasutada eeldusel, et patsiente jälgitakse hoolikalt (vt lõigud 4.4 ja 5.2).
English: 50 ml oral solution 120 ml oral solution
Estonian: 50 ml suukaudne lahus 120 ml suukaudne lahus
English: It is not known if rivastigmine is excreted into human milk.
Estonian: Ei ole teada, kas rivastigmiin eritub inimese rinnapiima.
English: • Fits (seizures)
Estonian: • hood (krambid)
English: Pharmacotherapeutic group: psychoanaleptics, anticholinesterases, ATC code: N06DA03 Rivastigmine is an acetyl- and butyrylcholinesterase inhibitor of the carbamate type, thought to facilitate cholinergic neurotransmission by slowing the degradation of acetylcholine released by functionally intact cholinergic neurones.
Estonian: Rivastigmiin on karbamaadi tüüpi atsetüül- ja buturüülkoliinesteraasi inhibiitor, mis arvatavalt lihtsustab koliinergilist närviülekannet, aeglustades funktsionaalselt intaktsete koliinergiliste neuronite vabastatava atsetüülkoliini degradatsiooni.
English: Cholinomimetics may induce or exacerbate urinary obstruction and seizures.
Estonian: Kolinomimeetikumid võivad vallandada või suurendada kusemistakistuse või krambihoogude teket.
English: Movement disorder Bradykinesia
Estonian: Liigutuste häired Bradükineesia Düstoonia
English: Fatigue and asthenia Gait disturbance Parkinson gait
Estonian: Kukkumine Väsimus ja asteenia Kõnnakuhäired Parkinsoni kõnnak
English: OTHER CODDITIONS AND REQUIREMENT OF THE MARKETING AUTHORISATION
Estonian: MÜÜGILOA MUUD TINGIMUSED JA NÕUDED
English: ITT: Intent-To-Treat; RDO: Retrieved Drop Outs
Estonian: ITT: ravikavatsuse alusel, RDO: Väljalangejad
English: The starting dose is 1.5 mg twice a day.
Estonian: Algannus on 1,5 mg kaks korda päevas.
English: Therefore, women on rivastigmine should not breast-feed.
Estonian: Seetõttu ei tohi rivastigmiinravi ajal last rinnaga toita.
English: Caution is recommended when selecting anaesthetic agents.
Estonian: Anesteetikumi tuleb valida ettevaatusega.
English: Some people who have accidentally taken too much Rivastigmine HEXAL have experienced feeling sick (nausea), being sick (vomiting), diarrhoea, high blood pressure and hallucinations.
Estonian: Osadel juhtudel on liiga suure Rivastigmine HEXAL'i annuse võtmisel tekkinud iiveldus, oksendamine, kõhulahtisus, kõrge vererõhk ja hallutsinatsioonid.
English: Cholinesterase inhibitors should be prescribed with care to patients with a history of asthma or obstructive pulmonary disease.
Estonian: Astma või obstruktiivse kopsuhaigusega patsientidele tuleb koliinesteraasi inhibiitoreid määrata ettevaatusega.
English: Adjusted treatment difference p-value versus placebo n/a
Estonian: Kohandatud ravi erinevus p-väärtus vs. platseebo mitte rakendatav
English: In animals, rivastigmine is excreted in milk.
Estonian: Loomadel eritub rivastigmiin rinnapiima.
English: However, due to increased exposure in these populations, dosing recommendations to titrate according to individual tolerability should be closely followed as patients with clinically significant renal or hepatic impairment might experience more dose-dependent adverse reactions.
Estonian: Sellegipoolest tuleks täpselt järgida annuse suurendamise juhiseid ja arvestada ravimi individuaalset talutavust, kuna ravimi sisaldus plasmas suureneb ja kliiniliselt olulise neeru- või maksakahjustusega patsientidel võib esineda rohkem annusest sõltuvaid kõrvaltoimeid.
English: If adverse reactions (e.g. nausea, vomiting, abdominal pain or loss of appetite), weight decrease or worsening of extrapyramidal symptoms (e.g. tremor) in patients with dementia associated with Parkinson's disease are observed during treatment, these may respond to omitting one or more doses.
Estonian: Kui Parkinsoni tõvega seotud dementsusega patsiendil tekivad kõrvaltoimed (nt iiveldus, oksendamine, kõhuvalu või isukadu), kehakaalu langus või ekstrapüramidaalnähtude (nt treemori) süvenemine, võivad need leevenduda, kui üks või enam annust vahele jätta.
English: Oral studies in pregnant rats and rabbits gave no indication of teratogenic potential on the part of rivastigmine.
Estonian: Tiinetel rottidel ja küülikutel suukaudsete ravimivormidega tehtud uuringud ei viidanud rivastigmiini teratogeensusele.
English: Each Rivastigmine HEXAL 1.5 mg capsule contains 1.5 mg of rivastigmine.
Estonian: Iga Rivastigmine HEXAL'i 1,5 mg kapsel sisaldab 1,5 mg rivastigmiini.
English: 6.6 Special precautions for disposal and other handling
Estonian: 6.6 Erihoiatused ravimpreparaadihävitamiseks ja käsitlemiseks
English: Sick sinus syndrome
Estonian: Siinussõlme nõrkuse sündroom
English: The active substance of Rivastigmine HEXAL is rivastigmine.
Estonian: Rivastigmine HEXAL'is sisalduv toimeaine on rivastigmiin.
English: Very common (may affect more than 1 in 10 people)
Estonian: Väga sage (võib mõjutada rohkem kui ühte inimest 10-st)
English: Bradycardia Arial fibrillation Atrioventricular block Sick sinus syndrome
Estonian: Kodade virvendus Atrioventrikulaarne blokaad Siinussõlme nõrkuse sündroom
English: Only for carton box: Rivastigmine HEXAL 2 mg/ml
Estonian: Ainult pappkarbil: Rivastigmine HEXAL, 2 mg/ml
English: Care should be exercised in treating patients with active gastric or duodenal ulcers or patients predisposed to these conditions.
Estonian: Aktiivse mao- või kaksteistsõrmiksoole haavandiga või eelsoodumusega patsientide ravimisel tuleb olla ettevaatlik.
English: Each Rivastigmine HEXAL 6 mg capsule contains 6 mg of rivastigmine.
Estonian: Iga Rivastigmine HEXAL'i 6 mg kapsel sisaldab 6 mg rivastigmiini.
English: • Push down and turn the child resistant cap to open bottle.
Estonian: • Pudeli avamiseks vajutage lastekindlat korki ning pöörake seda samaaegselt.
English: Each Rivastigmine HEXAL 4.5 mg capsule contains 4.5 mg of rivastigmine.
Estonian: Iga Rivastigmine HEXAL'i 4,5 mg kapsel sisaldab 4,5 mg rivastigmiini.
English: - Printing ink: - Shellac - Titanium dioxide (E171)
Estonian: Trükivärv: - šellak - titaandioksiid (E171)
English: • Take Rivastigmine HEXAL twice a day in the morning and evening with food.
Estonian: • Võtke Rivastigmine HEXAL'it kaks korda päevas toiduga (hommikuti ja õhtuti).
English: Urinary infection
Estonian: • kuseteede infektsioon
English: The oral solution is packaged with an oral dosing syringe in a plastic tube container.
Estonian: Suukaudse lahuse pakendis on kaasas plastümbrises annustamissüstal.
English: One of the inactive ingredients in Rivastigmine HEXAL oral solution is sodium benzoate.
Estonian: Üks Rivastigmine HEXAL suukaudse lahuse mitteaktiivsetest abiainetest on naatriumbensoaat.
English: - Capsule shell: - Gelatin - Titanium dioxide (E171) - Yellow iron oxide (E172) - Red iron oxide (E172)
Estonian: Kapsli kest: - želatiin - titaandioksiid (E171) - kollane raudoksiid (E172) - punane raudoksiid (E172)
English: Each Rivastigmine HEXAL 3 mg capsule contains 3 mg of rivastigmine.
Estonian: Iga Rivastigmine HEXAL'i 3 mg kapsel sisaldab 3 mg rivastigmiini.
English: To be swallowed whole without crushing or opening.
Estonian: Kapsel neelatakse purustamata ja avamata kujul tervena alla.
English: Parkinson's disease (worsening) Salivary hypersecretion Dyskinesia
Estonian: Parkinsoni tõbi (halvenemine) Sülje hüpersekretsioon
English: Some cases of severe vomiting were associated with oesophageal rupture (see section 4.8).
Estonian: Osade raske oksendamise juhtudega kaasnes söögitoru rebend (vt lõik 4.8).
English: Very rare (may affect up to 1 in 10,000 people)
Estonian: Väga harv (võib mõjutada kuni ühte inimest 10000-st)
English: • The signs of Parkinson's disease get worse or getting similar signs - such as stiff muscles,
Estonian: • Parkinsoni tõvele sarnaste sümptomite teke või süvenemine - lihasjäikus, liikumisraskus
English: • Inflammation of the pancreas - the signs include serious upper stomach pain, often with feeling sick (nausea) or being sick (vomiting)
Estonian: • kõhunäärme põletik - sümptomiteks on tugev ülakõhuvalu, halb enesetunne (iiveldus) või haigus
English: How to take Rivastigmine HEXAL
Estonian: Kuidas Rivastigmine HEXAL'it võtta
English: Rivastigmine should be administered twice a day, with morning and evening meals.
Estonian: Rivastigmiini manustatakse kaks korda päevas - hommiku- ja õhtusöögi ajal.
English: Some cases of severe vomiting were associated with oesophageal rupture (see section 4.4).
Estonian: Osade raske oksendamise juhtudega kaasnes söögitoru rebend (vt lõik 4.4).
English: - if you have, or have ever had, irregular or slow heartbeat.
Estonian: - kui teil esinevad või on kunagi esinenud südame rütmihäired või aeglane südame löögisagedus.
English: • Heartburn
Estonian: • pearinglus
English: - Capsule shell: - Gelatin - Titanium dioxide (E171) - Yellow iron oxide (E172)
Estonian: Kapsli kest: - želatiin - titaandioksiid (E171) - kollane raudoksiid (E172)
English: The Cmax of rivastigmine was approximately 60% higher and the AUC of rivastigmine was more than twice as high in subjects with mild to moderate hepatic impairment than in healthy subjects.
Estonian: Kerge kuni keskmise maksapuudulikkusega patsientidel oli rivastigmiini Cmax ligikaudu 60% suurem ning rivastigmiini AUC enam kui kaks korda suurem kui tervetel.
English: One of the excipients in Rivastigmine HEXAL oral solution is sodium benzoate.
Estonian: Rivastigmine HEXAL'i suukaudse lahuse üheks abiaineks on naatriumbensoaat.
English: Store in an upright position.
Estonian: Hoida püstiasendis.
English: Rivastigmine HEXAL 3 mg and 6 mg hard capsules:
Estonian: Rivastigmine HEXAL 3 mg ja 6 mg kõvakapslid
English: Only for carton box: Rivastigmine HEXAL 1.5 mg
Estonian: Ainult pappkarbil: Rivastigmine HEXAL, 1,5 mg
English: Symptomatic treatment of mild to moderately severe Alzheimer's dementia.
Estonian: Kerge kuni keskmise raskusega Alzheimeri tõve tüüpi dementsuse sümptomaatiline ravi.
English: • The highest dose that should be taken is 6.0 mg twice a day.
Estonian: • Kõrgeim ööpäevane annus on 6 mg, mis tuleb võtta kaks korda päevas.
English: Re-initiation of therapy
Estonian: Ravi uuesti alustamine
English: There is no relevant use of rivastigmine in the paediatric population in the treatment of Alzheimer's disease.
Estonian: Lapsed Puudub rivastigmiini asjakohane kasutamine Alzheimeri ravis lastel.
English: Worsening (including bradykinesia, dyskinesia, gait abnormality) and an increased incidence or severity of tremor have been observed in patients with dementia associated with Parkinson's disease (see section 4.8).
Estonian: Parkinsoni tõvega seotud dementsusega patsientidel on täheldatud raske treemori sagenemist ja süvenemist (sh bradükineesia, düskineesia, tasakaaluhäired) (vt lõik 4.8).
English: The results for clinically relevant responders pooled from two flexible dose studies out of the three pivotal 26-week multicentre studies in patients with mild-to-moderately severe Alzheimer's Dementia, are provided in Table 4 below.
Estonian: Tabelis 4 on toodud kerge kuni keskmise raskusega Alzheimeri tõvega haigete andmed, mis on kogutud kahes muudetava annusega uuringus kliiniliselt sobivate ravile reageerinute kohta (kokku tehti kolm pöördelist 26-nädalast mitmekeskuselist uuringut).
English: Additive effects leading to bradycardia (which may result in syncope) have been reported with the combined use of various beta-blockers (including atenolol) and rivastigmine.
Estonian: Mitmete beetablokaatorite (sh atenolool) ja rivastigmiini kooskasutamisel on teatatud koondtoimetest, mis põhjustavad bradükardiat (mis võib tekitada sünkoopi).
English: Only for carton box: Rivastigmine HEXAL 6 mg
Estonian: Ainult pappkarbil: Rivastigmine HEXAL, 6 mg
English: Only for carton box: Rivastigmine HEXAL 4.5 mg
Estonian: Ainult pappkarbil: Rivastigmine HEXAL, 4,5 mg
English: Each capsule contains 6 mg of rivastigmine (as hydrogen tartrate).
Estonian: Üks kapsel sisaldab 6 mg rivastigmiini (vesiniktartraadina).
English: - Printing ink: - Shellac - Red iron oxide (E172)
Estonian: Trükivärv: - šellak - punane raudoksiid (E172)
English: No dose adjustment is necessary for patients with mild to moderate renal or hepatic impairment.
Estonian: Kerge või mõõduka neeru- või maksapuudulikkusega patsientidel ei ole vaja annust muuta.
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 4,5 mg rivastigmine.
Estonian: Iga kapsel sisaldab rivastigmiinvesiniktartraati koguses, mis vastab 4,5 mg rivastigmiinile.
English: Rivastigmine HEXAL 1.5 mg hard capsules rivastigmine (as hydrogen tartrate)
Estonian: Rivastigmine HEXAL, 1,5 mg kõvakapslid rivastigmiin (vesiniktartraadina)
English: Each ml contains rivastigmine hydrogen tartrate corresponding to rivastigmine base 2.0 mg. - The other ingredients are: sodium benzoate, citric acid, sodium citrate, quinoline yellow WS dye (E104) and purified water.
Estonian: - Abiained on järgmised: naatriumbensoaat, sidrunhape, naatriumtsitraat, kinoliinkollane (E104) ja puhastatud vesi.
English: Other side effects seen with transdermal patches and which may occur with the hard capsules:
Estonian: Teised transdermaalse plaastri kõrvaltoimed ja kõvakapsli kõrvaltoimed:
English: Rivastigmine HEXAL 2 mg/ml oral solution rivastigmine (as hydrogen tartrate)
Estonian: Rivastigmine HEXAL, 2 mg/ml suukaudne lahus rivastigmiin (vesiniktartraadina)
English: • Anxiety
Estonian: • rahutus
English: PSURs
Estonian: Krambid
English: • Weight loss
Estonian: • kehakaalu langus
English: Rivastigmine HEXAL 4.5 mg hard capsules rivastigmine (as hydrogen tartrate)
Estonian: Rivastigmine HEXAL, 4,5 mg kõvakapslid rivastigmiin (vesiniktartraadina)
English: Each capsule contains 1.5 mg of rivastigmine (as hydrogen tartrate).
Estonian: Üks kapsel sisaldab 1,5 mg rivastigmiini (vesiniktartraadina).
English: Only for carton box: Rivastigmine HEXAL 3 mg
Estonian: Ainult pappkarbil: Rivastigmine HEXAL, 3 mg
English: - The active substance is rivastigmine hydrogen tartrate.
Estonian: Peamine eliminatsioon toimub metaboliitide renaalse ekskretsiooni teel.
English: Rivastigmine HEXAL 2 mg/ml oral solution
Estonian: Rivastigmine HEXAL 2 mg/ml suukaudne lahus
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 6 mg rivastigmine.
Estonian: Iga kapsel sisaldab rivastigmiinvesiniktartraati koguses, mis vastab 6 mg rivastigmiinile.
English: Each ml contains 2.0 mg of rivastigmine (as hydrogen tartrate).
Estonian: Üks ml sisaldab 2 mg rivastigmiini (vesiniktartraadina).
English: Restlessness Hallucination, visual Depression Aggression
Estonian: Nägemishallutsinatsioonid Depressioon
English: Sandoz dd
Estonian: Sandoz Pharmaceuticals DD
English: Each capsule contains 4.5 mg of rivastigmine (as hydrogen tartrate).
Estonian: Üks kapsel sisaldab 4,5 mg rivastigmiini (vesiniktartraadina).
English: - Rivastigmine HEXAL 4.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and red body, with a white imprint “RIV 4.5 mg” on the body.
Estonian: - Rivastigmine HEXAL'i 4,5 mg kõvakapslid, mis sisaldavad beeži kuni helekollast pulbrit, on punase kaanekese ja punase põhiosaga ning kapsli põhiosale on valgega trükitud „RIV 4,5 mg“.
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 1,5mg rivastigmine.
Estonian: Iga kapsel sisaldab rivastigmiinvesiniktartraati koguses, mis vastab 1,5 mg rivastigmiinile.
English: Rivastigmine HEXAL 6 mg hard capsules rivastigmine (as hydrogen tartrate)
Estonian: Rivastigmine HEXAL, 6 mg kõvakapslid rivastigmiin (vesiniktartraadina)
English: There is no relevant use of Rivastigmine HEXAL in the paediatric population in the treatment of Alzheimer's disease.
Estonian: Puudub Rivastigmine HEXAL'i asjakohane kasutamine Alzheimeri ravis lastel ja noorukitel.
English: If you are pregnant, the benefits of using Rivastigmine HEXAL must be assessed against the possible effects on your unborn child. Rivastigmine HEXAL should not be used during pregnancy unless clearly necessary.
Estonian: Raseduse korral tuleb kaaluda Rivastigmine HEXAL'i kasutamise eeliseid võrreldes selle võimaliku mõjuga lootele.
English: - Rivastigmine HEXAL 1.5 mg hard capsules, which contain an off-white to slightly yellow powder, have a yellow cap and yellow body, with a red imprint “RIV 1.5 mg” on the body.
Estonian: - Rivastigmine HEXAL'i 1,5 mg kõvakapslid, mis sisaldavad beeži kuni helekollast pulbrit, on kollase kaanekese ja kollase põhiosaga ning kapsli põhiosale on punasega trükitud „RIV 1,5 mg“.
English: Each capsule contains 3 mg of rivastigmine (as hydrogen tartrate).
Estonian: Üks kapsel sisaldab 3 mg rivastigmiini (vesiniktartraadina).
English: Quinoline yellow WS dye (E104) Purified water
Estonian: - Naatriumbensoaat - Sidrunhape - Naatriumtsitraat - Kinoliinkollane (E104) - Puhastatud vesi
English: Off-white to slightly yellow powder in a capsule with red cap and red body, with white imprint “RIV 4.5 mg” on the body.
Estonian: Beež kuni helekollane pulber punase kaanekese ning punase põhiosaga kapslis, mille põhiosale on valgega trükitud „RIV 4,5 mg“.
English: Rivastigmine oral solution should be administered twice a day, with morning and evening meals.
Estonian: Rivastigmiini suukaudset lahust manustatakse kaks korda päevas - hommiku- ja õhtusöögi ajal.
English: • Bleeding in the gut - shows as blood in stools or when being sick
Estonian: • seedekulgla verejooks - halb enesetunne või veri väljaheites
English: - Rivastigmine HEXAL 3 mg hard capsules, which contain an off-white to slightly yellow powder, have an orange cap and orange body, with a red imprint “RIV 3 mg” on the body.
Estonian: - Rivastigmine HEXAL'i 3 mg kõvakapslid, mis sisaldavad beeži kuni helekollast pulbrit, on oranži kaanekese ja oranži põhiosaga ning kapsli põhiosale on punasega trükitud „RIV 3 mg“.
English: Abdominal pain and dyspepsia Gastric and duodenal ulcers Gastrointestinal haemorrhage Pancreatitis
Estonian: Oksendamine Kõhulahtisus Kõhuvalu ja düspepsia Sülje hüpersekretsioon
English: Each capsule contains rivastigmine hydrogen tartrate corresponding to 3 mg rivastigmine.
Estonian: Iga kapsel sisaldab rivastigmiinvesiniktartraati koguses, mis vastab 3 mg rivastigmiinile.
English: Symptomatic treatment of mild to moderately severe dementia in patients with idiopathic Parkinson's disease.
Estonian: Idiopaatilise Parkinsoni tõvega patsientidel kerge kuni keskmise raskusega dementsuse sümptomaatiline ravi.
English: HOW TO STORE RIVASTIGMINE HEXAL
Estonian: Kuidas Rivastigmine HEXAL'IT säilitada
English: Rivastigmine HEXAL 3 mg hard capsules rivastigmine (as hydrogen tartrate)
Estonian: Rivastigmine HEXAL, 3 mg kõvakapslid rivastigmiin (vesiniktartraadina)
English: - Rivastigmine HEXAL 6 mg hard capsules, which contain an off-white to slightly yellow powder, have a red cap and orange body, with a red imprint “RIV 6 mg” on the body.
Estonian: - Rivastigmine HEXAL'i 6 mg kõvakapslid, mis sisaldavad beeži kuni helekollast pulbrit, on punase kaanekese ja oranži põhiosaga ning kapsli põhiosale on punasega trükitud „RIV 6 mg“.
English: Uncommon (may affect up to 1 in 100 people)
Estonian: Sage (võib mõjutada kuni ühte inimest 100-st)
English: Off-white to slightly yellow powder in a capsule with orange cap and orange body, with red imprint “RIV 3 mg” on the body.
Estonian: Beež kuni helekollane pulber oranži kaanekese ning oranži põhiosaga kapslis, mille põhiosale on punasega trükitud „RIV 3 mg“.
English: No untoward effects on cardiac conduction were observed following concomitant administration of digoxin and rivastigmine.
Estonian: Digoksiini ja rivastigmiini koos manustamisel ei täheldatud mõju südame juhtesüsteemile.
English: • difficulty in carrying out movements and muscle weakness
Estonian: • ebaregulaarne südamerütm ja halb liigutuste kontroll
English: Off-white to slightly yellow powder in a capsule with yellow cap and yellow body, with red imprint “RIV 1.5 mg” on the body.
Estonian: Beež kuni helekollane pulber kollase kaanekese ning kollase põhiosaga kapslis, mille põhiosale on punasega trükitud „RIV 1,5 mg“.
English: Off-white to slightly yellow powder in a capsule with red cap and orange body, with red imprint “RIV 6 mg” on the body.
Estonian: Beež kuni helekollane pulber punase kaanekese ning oranži põhiosaga kapslis, mille põhiosale on punasega trükitud „RIV 6 mg“.
English: Other side effects seen with transdermal patches and which may occur with the oral solution:
Estonian: Teised transdermaalse plaastri kõrvaltoimed ja suukaudne lahus:
English: (n=158) n/a
Estonian: (n=158) mitte rakendatav
English: Each ml contains rivastigmine hydrogen tartrate corresponding to 2g rivastigmine.
Estonian: Iga ml sisaldab rivastigmiinvesiniktartraati koguses, mis vastab 2 mg rivastigmiinalusele.
English: Common (may affect up to 1 in 10 people)
Estonian: Sage (võib mõjutada kuni ühte inimest 10-st)
English: Hepatic impairment
Estonian: Agitatsioon Segasus
English: (n=289) n/a
Estonian: (n=289) mitte rakendatav
English: (n=165) n/a
Estonian: (n=165) mitte rakendatav
English: Cmax and AUC of rivastigmine were more than twice as high in subjects with moderate renal impairment compared with healthy subjects; however there were no changes in Cmax and AUC of rivastigmine in subjects with severe renal impairment.
Estonian: Rivastigmiini Cmax ja AUC olid keskmise neerupuudulikkusega patsientidel rohkem kui kaks korda suuremad kui tervetel.
English: Rivastigmine HEXAL 1.5 mg hard capsules:
Estonian: Rivastigmine HEXAL 1,5 mg kõvakapslid
English: Abdominal pain and dyspepsia Salivary hypersecretion
Estonian: Parkinsoni tõbi (halvenemine) Sülje hüpersekretsioon Düskineesia
English: Rare Very rare
Estonian: Harv Väga harv
English: • Fainting
Estonian: • unehäired
English: • Check the dose is still correct.
Estonian: • Kontrollige lahuse annust.
English: difficulty in carrying out movements
Estonian: Liigutuste häired
English: EU/1/09/589/001 EU/1/09/589/002 EU/1/09/589/003 EU/1/09/589/004
Estonian: EU/1/09/589/002 EU/1/09/589/003 EU/1/09/589/004
English: Rivastigmine HEXAL 4.5 mg hard capsules:
Estonian: Rivastigmine HEXAL 4,5 mg kõvakapslid
English: • Severe confusion
Estonian: • raske segasusseisund
English: Hexal S.p.A. c/o Sandoz S.p.A. Largo Umberto Boccioni 1 I-21040 Origgio / VA Tel: + 39-02-96 541
Estonian: I-21040 Origgio / VA Tel: + 39-02-96 541
English: Gastrointestinal disorders
Estonian: Hammasrattafenomen Düstoonia
English: Rare (may affect up to 1 in 1,000 people)
Estonian: Harv (võib mõjutada kuni ühte inimest 1000-st)
English: (n=329) n/a
Estonian: (n=329) mitte rakendatav
English: Skin and subcutaneous tissue disorders
Estonian: Kõhuvalu ja düspepsia Mao- ja kaksteistsõrmiksoole haavandid Seedetrakti verejooks
English: blisters.
Estonian: Pearinglus